Impact of beta‐blocker use on the long‐term outcomes of heart failure patients with chronic obstructive pulmonary disease

Author:

Kubota Yoshiaki1,Tay Wan Ting2,Teng Tiew‐Hwa Katherine2,Asai Kuniya1,Noda Takashi3,Kusano Kengo3,Suzuki Atsushi4,Hagiwara Nobuhisa4,Hisatake Shinji5,Ikeda Takanori5,Yasuoka Ryobun6,Kurita Takashi6,Shimizu Wataru1,

Affiliation:

1. Department of Cardiovascular Medicine Nippon Medical School 1‐1‐5, Sendagi, Bunkyo‐ku Tokyo 113‐0022 Japan

2. National Heart Centre Singapore Singapore

3. Division of Cardiology, Department of Internal Medicine National Cerebral and Cardiovascular Center Hospital Osaka Japan

4. Department of Cardiology Tokyo Women's Medical University School of Medicine Tokyo Japan

5. Division of Cardiovascular Medicine, Department of Internal Medicine Toho University Omori Hospital Tokyo Japan

6. Division of Cardiology, Department of Internal Medicine Kindai University School of Medicine Osaka Japan

Funder

Boston Scientific Corporation

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Understanding the Epidemiology of Heart Failure to Improve Management Practices: An Asia-Pacific Perspective

2. Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry

3. Chronic obstructive pulmonary disease and β-blocker treatment in Asian patients with heart failure

4. Clinical effects of β‐adrenergic blockade in chronic heart failure: a meta‐analysis of double‐blind, placebo‐controlled, randomized trials;Philippe L;Circ Am Heart Assoc,1998

5. ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America;Yancy Clyde W;Circulation American Heart Association,2017

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3